7 March 2018

Saskia de Wildt and colleagues, theme Renal disorders, obtained an EU Horizon 2020 grant of € 123.000 for a new research infrastructure that will facilitate the future development of better paediatric medicines.

Children and young people represent 20 % of the European population. When we refer to this group of people as patients, it’s essential to consider that they are different from the adult patients. Their metabolism is different, because they are in continuous development and also they can suffer diseases that sometimes might be limited to the paediatric setting.Taking into consideration these specificities, the need of treatments addressed only for children is a public priority. Nowadays around 50% of the medicines that are prescribed to paediatric patients have not been tested specially for them. For this reason, it is essential to promote and increase paediatric research.
The translation between bench to the bedside requires the involvement of different expert research groups in drug early discovery, biomarkers, formulation, pharmacology, etc. that already collaborate in Europe within the already existing research infrastructures. But the problem is that they do not are specifically dedicated to research in children.The time needed for the development of new medicines is also an important concern. It is long, from the basic research (before the study of a potential treatment with humans) to the clinical research (when we study this potential treatment with patients). It can also take among 7-10 years from the screening of new molecules to the market of a new drug and the average of success rate is really low (1 over 10.000 molecules studied). For this reason, it's essential to join efforts and work in a collaborative way between the European experts groups that at this moment are working to develop paediatric medicines.
ID-EPTRI is a project funded by the European Commission that has as main objective to design the framework for the European Paediatric Translational Research Infrastructure (EPTRI). A research infrastructure is a set of facilities, resources and related services at disposal of the scientific community to conduct top-level research. EPTRI will be a new research infrastructure that will integrate the paediatric expertise of five different areas of pre-clinical research: early discovery and preclinical studies, biomarkers, pharmacology, formulation and underpinning paediatric studies. The main objective of ID-EPTRI is to facilitate the paediatric pre-clinical research while reducing the time of its translation to the clinical phase.
The project involves 26 partners from EU and non-EU countries including already existing research infrastructures, top-level universities, scientific and clinical centers of excellence in Europe. It is coordinated by Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF), a not-for-profit organization, founded in 2000 with the mission to perform research and provide scientific, economic and regulatory consultancy for innovation in the health sector at European level.

Saskia de Wildt, project leader, is member of the theme Renal disorders.
Project: https://www.cvbf.net/eptri/
 

Related news items


Adjunct Professorship awarded to Barbara Franke at the Goethe University in Frankfurt am Main

21 January 2019

Barbara Franke is awarded an honorary Adjunct Professorship at the Goethe University in Frankfurt am Main in Germany.

read more

Two papers on molecular mechanisms of GFI1B in inherited bleeding syndromes in Haematologica

21 January 2019

Rinske van Oorschot from the Van der Reijden group, theme Cancer development and immune defense, has published two papers on the transcription factor GFI1B in Haematologica.

read more

Blog: Species Differences The Elephant in the Room

17 January 2019

Read the blog of Merel Ritskes-Hoitinga in the New England anti-vivisection society (neavs) based on a paper published in the Journal of Translational Medicine.

read more

Bart-Jan Kullberg nominated for ZonMw Medical Inspirator Award

17 January 2019

This prize is awarded for the most inspiring collaboration between patients and medical researchers. You can vote till 11 February.

read more

Richard Grol Award for Heather Whitson

17 January 2019

RIHS has awarded the Richard Grol Visiting Scientist Award 2018 to Heather Whitson, Associate Professor of Medicine with Tenure in the Duke University School of Medicine in Durham, North Carolina, USA.

read more

Annual CaRe days 8 & 9 May 2019

17 January 2019

The CaRe days provides an inspiring program for all RIHS researchers. Program is online and registration is open.

read more
  • Go to